G&S Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Sell
4,477
-13
-0.3% -$3.03K 0.33% 84
2026
Q1
$1.1M Buy
4,490
+44
+1% +$10.2K 0.39% 74
2025
Q4
$920K Buy
4,446
+31
+0.7% +$6.13K 0.33% 81
2025
Q3
$819K Sell
4,415
-580
-12% -$99.4K 0.3% 84
2025
Q2
$763K Buy
4,995
+69
+1% +$10.6K 0.3% 84
2025
Q1
$817K Sell
4,926
-82
-2% -$12.8K 0.35% 77
2024
Q4
$724K Sell
5,008
-19
-0.4% -$2.94K 0.3% 82
2024
Q3
$815K Buy
5,027
+91
+2% +$14.5K 0.34% 83
2024
Q2
$737K Sell
4,936
-113
-2% -$16.8K 0.32% 81
2024
Q1
$799K Sell
5,049
-14,715
-74% -$2.34M 0.36% 78
2023
Q4
$3.1M Sell
19,764
-289
-1% -$44.3K 1.47% 16
2023
Q3
$3.12M Sell
20,053
-148
-0.7% -$24.4K 1.59% 11
2023
Q2
$3.34M Buy
20,201
+7,150
+55% +$1.15M 1.61% 10
2023
Q1
$2.02M Buy
13,051
+8,254
+172% +$1.33M 0.89% 33
2022
Q4
$847K Buy
4,797
+67
+1% +$11.6K 0.38% 71
2022
Q3
$773K Buy
4,730
+69
+1% +$11.7K 0.41% 64
2022
Q2
$827K Buy
4,661
+4
+0.1% +$713 0.49% 60
2022
Q1
$825K Sell
4,657
-189
-4% -$32.2K 0.44% 69
2021
Q4
$829K Sell
4,846
-84
-2% -$13.8K 0.41% 70
2021
Q3
$796K Buy
4,930
+99
+2% +$16.9K 0.44% 68
2021
Q2
$796K Buy
4,831
+3
+0.1% +$497 0.42% 65
2021
Q1
$793K Sell
4,828
-69
-1% -$11.2K 0.46% 69
2020
Q4
$771K Sell
4,897
-22,119
-82% -$3.26M 0.46% 59
2020
Q3
$4.02M Buy
27,016
+11,181
+71% +$1.65M 2.91% 5
2020
Q2
$2.23M Sell
15,835
-13,544
-46% -$1.97M 1.99% 16
2020
Q1
$3.85M Buy
29,379
+16,050
+120% +$2.28M 6.74% 2
2019
Q4
$1.94M Buy
13,329
+8,661
+186% +$1.17M 1.1% 31
2019
Q3
$604K Buy
4,668
+84
+2% +$11.1K 0.35% 58
2019
Q2
$638K Sell
4,584
-756
-14% -$105K 0.38% 60
2019
Q1
$747K Sell
5,340
-116
-2% -$15.5K 0.46% 46
2018
Q4
$704K Sell
5,456
-94
-2% -$13.1K 0.64% 31
2018
Q3
$767K Buy
5,550
+86
+2% +$11.4K 0.53% 43
2018
Q2
$663K Buy
5,464
+1
+0% +$125 0.51% 44
2018
Q1
$700K Buy
5,463
+34
+0.6% +$4.6K 0.59% 33
2017
Q4
$759K Buy
+5,429
New +$756K 0.56% 37

Other funds holding JNJ

G&S Capital's JNJ Position: Q2 2026 in Review

G&S Capital reduced its Johnson & Johnson (JNJ) stake by 0.29% in Q2 2026, selling an estimated $3.03K and leaving 4,477 shares worth $1.14M. The position accounts for 0.33% of the portfolio, ranked #84.

G&S Capital first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. The position peaked at $4.02M in Q3 2020. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • G&S Capital held 4,477 shares of Johnson & Johnson worth $1.14M as of Q2 2026.
  • G&S Capital sold 13 Johnson & Johnson shares in Q2 2026, an estimated $3.03K.
  • Johnson & Johnson made up 0.33% of G&S Capital's portfolio in Q2 2026, its #84 holding.
  • G&S Capital first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
  • G&S Capital's Johnson & Johnson position peaked at $4.02M in Q3 2020.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on G&S Capital's 13F filing for Q2 2026, filed 10 Jul 2026.